Epinephrine Auto-Injectors Shortage
Last Updated: June 25, 2025
Status: Current
Products Affected - Description
-
- EpiPen injection, Mylan (Viatris), 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0500-02
- EpiPen Jr injection, Mylan (Viatris), 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0501-02
- Symjepi injection, Sandoz, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00781-3442-20 - discontinued
Reason for the Shortage
-
- Amneal has epinephrine auto-injectors available.
- Kaleo has Auvi-Q available only through specific distributors.
- Mylan did not provide a reason for the shortage of EpiPen and EpiPen Jr.
- Teva has epinephrine auto-injectors available.
- US Worldmeds no longer manufactures Symjepi.
Available Products
-
- Auvi-Q injection, Kaleo, 0.1 mg/0.1 mL, auto-injector, 2 count, NDC 60842-0021-01
- Auvi-Q injection, Kaleo, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 60842-0022-01
- Auvi-Q injection, Kaleo, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 60842-0023-01
- Epinephrine injection, Amneal, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 00115-1695-49
- Epinephrine injection, Amneal, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00115-1694-49
- Epinephrine injection, Mylan (Viatris), 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0101-02
- Epinephrine injection, Mylan (Viatris), 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0102-02
- Epinephrine injection, Teva, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5985-27
- Epinephrine injection, Teva, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5986-27
Estimated Resupply Dates
-
- Mylan has EpiPen and EpiPen Jr auto-injectors on back order and the company cannot estimate a release date.
Updated
Updated June 25, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.